First Manhattan
TARO

First Manhattan’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

First Manhattan’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-35,254
Closed -$3.81M – 1457
2019
Q1 		$3.81M Buy
+35,254
New +$3.51M 0.02% 272

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

First Manhattan's TARO Position: Q2 2019 in Review

First Manhattan sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2019, closing a stake of 35,254 shares — an estimated $3.81M sold.

First Manhattan first reported a position in TARO in Q1 2019 and held it in 1 quarter. The position peaked at $3.81M in Q1 2019. 105 funds tracked by Wall St. Rank hold TARO as of Q2 2019.

  • First Manhattan reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2019 after selling out during the quarter.
  • First Manhattan sold 35,254 Taro Pharmaceutical Industries Ltd. shares in Q2 2019, an estimated $3.81M.
  • First Manhattan first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2019 and held it in 1 quarter.
  • First Manhattan's Taro Pharmaceutical Industries Ltd. position peaked at $3.81M in Q1 2019.
  • 105 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2019.

Based on First Manhattan's 13F filing for Q2 2019, filed 16 Aug 2019.